Literature DB >> 2435342

Fetal hemoglobin-containing cells have the same mean corpuscular hemoglobin as cells without fetal hemoglobin: a reciprocal relationship between gamma- and beta-globin gene expression in normal subjects and in those with high fetal hemoglobin production.

G J Dover, S H Boyer.   

Abstract

We have developed methodology that allows comparison of the mean corpuscular hemoglobin (MCH) of fetal hemoglobin (HbF)-containing red cells (F cells) with the MCH of non-F cells from the same individual. To do this, suspensions of peripheral blood erythrocytes and their internal contents are fixed with an imidodiester, dimethyl-3,3'-dithiobispropionimidate dihydrochloride (DTBP). Thereafter fixed cells are made permeable to antisera by treatment with Triton X-100 and isopropanol, reacted with a mouse monoclonal antibody (MoAb) against HbF, and then with fluorescein-conjugated antimouse IgG. No appreciable hemoglobin is lost during such manipulation. Red cells from a diversity of subjects were thus treated and examined microscopically, first by transmitted light and then by epifluorescence. A direct correlation between Coulter-derived MCH and mean absorbance of 415 nm transmitted light was found for 100 unfixed (r = 0.96) and for 100 antibody-treated fixed-permeabilized red cells (r = 0.99) among individuals selected so as to provide a range of Coulter MCH values between 20 and 35. Comparisons of microscopically derived MCH of F cells and non-F cells were statistically nondistinguishable (P greater than 0.05) in all subjects. Such comparisons included normal individuals (less than 1% F cells), SS patients (7% to 48% F cells), subjects with congenital anemia (22% to 65% F cells), individuals with heterocellular hereditary persistence of HbF (HPFH) (12% to 21% F cells), and heterozygotes for beta + thalassemia (11% to 31% F cells). We conclude that gamma- and beta-globin production within F cells is regulated in a reciprocal fashion both among normal individuals and among individuals with elevated HbF production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435342

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Specific repression of beta-globin promoter activity by nuclear ferritin.

Authors:  R H Broyles; V Belegu; C R DeWitt; S N Shah; C A Stewart; Q N Pye; R A Floyd
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

2.  HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.

Authors:  Jean-Benoît Arlet; Jean-Antoine Ribeil; Flavia Guillem; Olivier Negre; Adonis Hazoume; Guillaume Marcion; Yves Beuzard; Michaël Dussiot; Ivan Cruz Moura; Samuel Demarest; Isaure Chauvot de Beauchêne; Zakia Belaid-Choucair; Margaux Sevin; Thiago Trovati Maciel; Christian Auclair; Philippe Leboulch; Stany Chretien; Luba Tchertanov; Véronique Baudin-Creuza; Renaud Seigneuric; Michaela Fontenay; Carmen Garrido; Olivier Hermine; Geneviève Courtois
Journal:  Nature       Date:  2014-08-24       Impact factor: 49.962

3.  BP1, a homeodomain-containing isoform of DLX4, represses the beta-globin gene.

Authors:  Michael B Chase; Sidong Fu; Susanne B Haga; Gregory Davenport; Holly Stevenson; Khanh Do; Doris Morgan; Alex L Mah; Patricia E Berg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Analyses of linked beta-globin genes suggest that nondeletion forms of hereditary persistence of fetal hemoglobin are bona fide switching mutants.

Authors:  J E Metherall; F P Gillespie; B G Forget
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

5.  Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.

Authors:  Rodwell Mabaera; Michael R Greene; Christine A Richardson; Sarah J Conine; Courtney D Kozul; Christopher H Lowrey
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

6.  Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.

Authors:  Duyen Ngo; Harold Bae; Martin H Steinberg; Paola Sebastiani; Nadia Solovieff; Clinton T Baldwin; Efthymia Melista; Surinder Safaya; Lindsay A Farrer; Ahmed M Al-Suliman; Waleed H Albuali; Muneer H Al Bagshi; Zaki Naserullah; Idowu Akinsheye; Patrick Gallagher; Hong-yuan Luo; David H K Chui; John J Farrell; Amein K Al-Ali; Abdulrahman Alsultan
Journal:  Blood Cells Mol Dis       Date:  2013-03-07       Impact factor: 3.039

Review 7.  Heterogeneity of fetal hemoglobin production in adult red blood cells.

Authors:  Eugene Khandros; Gerd A Blobel
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.284

Review 8.  Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs.

Authors:  Filomena Longo; Andrea Piolatto; Giovanni Battista Ferrero; Antonio Piga
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

9.  Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.

Authors:  Siana Nkya Mtatiro; Julie Makani; Bruno Mmbando; Swee Lay Thein; Stephan Menzel; Sharon E Cox
Journal:  Am J Hematol       Date:  2014-10-20       Impact factor: 10.047

10.  Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies.

Authors:  Constantinos C Loucari; Petros Patsali; Thamar B van Dijk; Coralea Stephanou; Panayiota Papasavva; Maria Zanti; Ryo Kurita; Yukio Nakamura; Soteroulla Christou; Maria Sitarou; Sjaak Philipsen; Carsten W Lederer; Marina Kleanthous
Journal:  Hum Gene Ther Methods       Date:  2018-02       Impact factor: 2.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.